e-learning
resources
Berlin 2008
Monday, 06.10.2008
Inflammatory trigger mechanisms in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of active smoking on systemic TNF-α concentration in COPD patients
S. Tanni, A. Angeleli, N. Pelegrino, C. Correa-Camacho, C. Correa, L. Inoue, I. Godoy (Botucatu/Sao Paulo, Brazil; Seatle, WA, United States Of America)
Source:
Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Session:
Inflammatory trigger mechanisms in asthma and COPD
Session type:
E-Communication Session
Number:
1816
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Tanni, A. Angeleli, N. Pelegrino, C. Correa-Camacho, C. Correa, L. Inoue, I. Godoy (Botucatu/Sao Paulo, Brazil; Seatle, WA, United States Of America). Influence of active smoking on systemic TNF-α concentration in COPD patients. Eur Respir J 2008; 32: Suppl. 52, 1816
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005
The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003
Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
The tobacco smoking influence on parodontic inflammation in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 167s
Year: 2007
Systemic inflammation in COPD in relation to smoking status
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020
Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Effects of smoking history on the benefits of pulmonary rehabilitation in patients with COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
The influence of smoking on the treatment response in patients with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
Influence of smoking intensity and smoking quitting on lung function parameters in COPD patients
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Influence of tobacco-smoking and it intensification on systemic inflammatory state (sis) in COPD patients
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Effects of smoking cessation in COPD
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006
Influence of statin therapy on exacerbation frequency in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008
Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Year: 2017
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Year: 2017
Comparison of osteoporosis in male smokers with or without COPD
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Influence of tobacco smoking on respiratory muscles function in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept